RE: CA 19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Preoperative Therapy

被引:5
作者
Bold, Richard J. [1 ]
机构
[1] Calif State Univ Sacramento, Davis Med Ctr, Dept Surg, Sacramento, CA 95819 USA
关键词
TUMOR-MARKERS; OBSTRUCTIVE-JAUNDICE; SERUM; CARCINOMA; BILIRUBIN; ANTIGEN; PREDICT; CA19-9;
D O I
10.1245/s10434-012-2820-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:2108 / 2110
页数:3
相关论文
共 19 条
[1]   TUMOR-MARKERS - VALUE AND LIMITATIONS IN THE MANAGEMENT OF CANCER-PATIENTS [J].
BATES, SE ;
LONGO, DL .
CANCER TREATMENT REVIEWS, 1985, 12 (03) :163-207
[2]  
Brody JR, 2011, ADV SURG, V45
[3]   The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancer [J].
Crane, CH ;
Varadhachary, G ;
Wolff, RA ;
Pisters, PWT ;
Evans, DB .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2006, 20 (02) :365-382
[4]  
Del Villano BC, 1983, LAB RES METHODS BIOL, V8
[5]  
DELVILLANO BC, 1983, CLIN CHEM, V29, P549
[6]  
Hartwig A, 2012, ANN SURG ONCOL, DOI [10.1245/s10434-012-2809-1, DOI 10.1245/S10434-012-2809-1.(EPUB]
[7]  
JACOBS EL, 1991, CURR PROB CANCER, V15, P299
[8]   The use of adjusted preoperative CA 19-9 to predict the recurrence of resectable pancreatic cancer [J].
Kang, Chang Moo ;
Kim, Jun Young ;
Choi, Gi Hong ;
Kim, Kyung Sik ;
Choi, Jin Sub ;
Lee, Woo Jung ;
Kim, Byong Ro .
JOURNAL OF SURGICAL RESEARCH, 2007, 140 (01) :31-35
[9]   COLORECTAL-CARCINOMA ANTIGENS DETECTED BY HYBRIDOMA ANTIBODIES [J].
KOPROWSKI, H ;
STEPLEWSKI, Z ;
MITCHELL, K ;
HERLYN, M ;
HERLYN, D ;
FUHRER, P .
SOMATIC CELL GENETICS, 1979, 5 (06) :957-972
[10]   SPECIFIC ANTIGEN IN SERUM OF PATIENTS WITH COLON-CARCINOMA [J].
KOPROWSKI, H ;
HERLYN, M ;
STEPLEWSKI, Z ;
SEARS, HF .
SCIENCE, 1981, 212 (4490) :53-55